Form 4: Pulmonx Director Daniel Florin Increases Stake with Significant Stock Purchase

Pulmonx Corporation's Director, Daniel P. Florin, has acquired 23,321 shares of common stock, increasing his beneficial ownership to 117,231 shares.

Summary

• Daniel P. Florin, a Director of Pulmonx Corp (LUNG), purchased 23,321 shares of common stock on June 5, 2025.
• The shares were acquired at a weighted average price of $3.06 per share, with individual transactions ranging from $3.01 to $3.09.
• Following this transaction, Mr. Florin beneficially owns a total of 117,231 shares of Pulmonx common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) trading plan.

Sentiment

Score: 8

Explanation: The purchase of a significant number of shares by a company director indicates strong insider confidence, which is generally viewed very positively by the market.

Positives

• A Director, Daniel P. Florin, increased his stake in Pulmonx Corp by purchasing 23,321 shares, signaling confidence in the company's future prospects.
• The purchase was made at a weighted average price of $3.06 per share, indicating a specific valuation at which the insider found the stock attractive.
• The transaction was executed under a Rule 10b5-1(c) trading plan, which suggests a pre-planned investment decision rather than a reaction to immediate market events.

Future Outlook

This Form 4 filing does not provide any explicit forward-looking statements or guidance.

Industry Context

This Form 4 filing, detailing an insider stock purchase, does not provide information related to broader industry trends or competitors. It solely reports a change in beneficial ownership by a company director.

Comparison to Industry Standards

• This document is an insider transaction report (Form 4) and does not contain information that allows for a direct comparison to industry-specific financial or operational benchmarks. Its primary purpose is to disclose changes in beneficial ownership by company insiders.

Corporate Governance

Related Party Transactions

• The reported transaction itself is a related party transaction, as it involves a company director purchasing shares of the issuer.

Stakeholder Impact

• Shareholders: The insider purchase may instill greater confidence among existing shareholders and potentially attract new investors, as it signals management's belief in the company's value.
• Employees: While not directly impacted, a positive signal from leadership can indirectly boost employee morale and confidence in the company's stability and future.

Key Dates

Recommendation

Keywords

Pulmonx Corp, LUNG, Insider Trading, Form 4, Stock Purchase, Director, Equity Acquisition, Beneficial Ownership, Rule 10b5-1